Form 4 for ELV Elevance Health

Accepted 2025-07-18 00:00:00 ET · period of report 2025-07-18 · accession 0001287920-25-000005 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2025-07-18	2025-07-18	ELV	BOUDREAUX GAIL	Pres, CEO, Dir	P - Purchase	$286.94	+8,500	151.0K	+6%	+$2.44M

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2025-07-18	P	A	2,334	$286.07	144,854	D	—	—	(F1) This transaction was executed in multiple purchases at prices ranging from $285.50 to $286.43. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
2	Common	Common Stock	2025-07-18	P	A	5,116	$287.12	149,970	D	—	—	(F2) This transaction was executed in multiple purchases at prices ranging from $286.70 to $287.69. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
3	Common	Common Stock	2025-07-18	P	A	1,050	$287.96	151,020	D	—	—	(F3) This transaction was executed in multiple purchases at prices ranging from $287.72 to $288.14. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.